Chief Medical Officer · Tyra Biosciences, Inc. (TYRA)

Hiroomi Tada

A named executive officer of Tyra Biosciences in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,412,417

Salary $509,600Stock awards $0

FY2022: $1,266,737

3rd of 4 named executive officers at Tyra Biosciences by FY2023 total.

4 named officers on file for Tyra Biosciences, FY2023

Hiroomi Tada’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tyra Biosciences’s whole pay program stands against its peers

  • Tyra Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TYRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2024 (DEF 14A).

Free

Get Hiroomi Tada’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Hiroomi Tada compensation by year

Tyra Biosciences Summary Compensation Table · all 3 fiscal years held
In US dollars, as Tyra Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$403,778$486,250$509,600
Bonus$0$0$0
Stock awards$0$0$0
Option awards$1,991,713$563,937$1,596,107
Non-equity incentive$114,735$215,600$305,760
Pension and deferred compensation$0$0$0
All other$1,135$950$950
Total$2,511,361$1,266,737$2,412,417

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tyra Biosciences, Inc. DEF 14A filed April 18, 2024, accession 0001193125-24-100755, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tyra Biosciences, Inc. filed document, accession 0001193125-24-100755. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2024.

$2.5M
$1.3M
$2.4M
FY21
FY22
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option75,625—$7.14
Option103,021—$14.35
Option42,168—$2.25
Option40,071—$24.15

Per the Outstanding Equity Awards at Fiscal Year-End table in Tyra Biosciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Tyra Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Todd HarrisChief Executive Officer$4,626,119
Alan FuhrmanChief Financial Officer$3,530,805
Hiroomi Tada · this pageChief Medical Officer$2,412,417
Daniel BensenChief Operating Officer$1,919,933

The full Tyra Biosciences compensation record

free company brief

This page is one person within Tyra Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tyra Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hiroomi Tada's compensation dossier · One-time report. No refunds.